Yu Liu

Yu Liu

Auto-generated profile, based on publicly available information

Yu Liu

University of Houston

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JIJose Francisco Islas
Jose Francisco Islas
YLYu Liu
Yu Liu
KWKuo-Chan Weng
Kuo-Chan Weng
MRMatthew J. Robertson
Matthew J. Robertson
SZShuxing Zhang
Shuxing Zhang
RSRobert J. Schwartz
Robert J. Schwartz
Unique insights for the reprograming of cell lineages have come from embryonic development in the ascidian Ciona , which is dependent upon the transcription factors Ci -ets1/2 and Ci -mesp to generate cardiac progenitors. We tested the idea that mammalian v-ets erythroblastosis virus E26 oncogene homolog 2 (ETS2) and mesoderm posterior (MESP) homolog may be used to convert human dermal fibroblasts into cardiac progenitors. Here we show that murine ETS2 has a critical role in directing cardiac progenitors during cardiopoiesis in embryonic stem cells. We then use lentivirus-mediated forced expression of human ETS2 to convert normal human dermal fibroblasts into replicative cells expressing the cardiac mesoderm marker KDR + . However, although neither ETS2 nor the purported cardiac master regulator MESP1 can by themselves generate cardiac progenitors de novo from fibroblasts, forced coexpression of ETS2 and MESP1 or cell treatment with purified proteins reprograms fibroblasts into cardiac progenitors, as shown by the de novo appearance of core cardiac transcription factors, Ca 2+ transients, and sarcomeres. Our data indicate that ETS2 and MESP1 play important roles in a genetic network that governs cardiopoiesis.

1 June 2002 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
STSai Wah Tsao
Sai Wah Tsao
XWXianghong Wang
Xianghong Wang
YLYu Liu
Yu Liu
YCYuk Chun Cheung
Yuk Chun Cheung
HFHuichen Feng
Huichen Feng
DHD.P Huang
D.P Huang

6 March 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YLYu Liu
Yu Liu
MAMasanori Asakura
Masanori Asakura
HIHironori Inoue
Hironori Inoue
TNTeruya Nakamura
Teruya Nakamura
MSMotoaki Sano
Motoaki Sano
MSMichael D. Schneider
Michael D. Schneider
Early steps for cardiac specification are problematic for the study of mammalian embryos, which has favored using pluripotent cells that recapitulate cardiac myogenesis. Furthermore, circuits governing cardiac specification have relevance to the application of ES cells and other cells for heart repair. In mouse teratocarcinoma cells, canonical Wnts that inhibit heart formation in avian or amphibian embryos and explants activate cardiogenesis, paradoxically. Here, we show that the Wnt/β-catenin pathway also is essential for cardiac myogenesis to occur in ES cells, acting at a gastrulation-like stage, mediating mesoderm formation and patterning (two prerequisites for cardiac myogenesis itself). Among genes associated temporally with this step was Sox17 , encoding an endodermal HMG-box transcription factor. Using lentiviral vectors for RNA interference in differentiating ES cells, an essential role for Sox17 was proven in cardiac muscle cell formation. Sox17 short-hairpin RNA suppresses cardiac myogenesis selectively, acting subsequent to mesoderm formation yet before induction of Mesp1 and Mesp2 , a pair of related basic helix–loop–helix transcription factors that together are indispensable for creating heart mesoderm. Sox17 short-hairpin RNA blocks cardiac myogenesis non-cell autonomously and impairs the induction of Hex, a homeodomain transcription factor that is known to be required for the production of endoderm-derived heart-inducing factors.

1 December 2000 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
XWXianghong Wang
Xianghong Wang
Dong-Yan JinDong-Yan Jin
Dong-Yan Jin
YWY.C. Wong
Y.C. Wong
ACAnnie L.M. Cheung
Annie L.M. Cheung
ACAbel C.S. Chun
Abel C.S. Chun
STSai Wah Tsao
Sai Wah Tsao
Nasopharyngeal carcinoma (NPC) occurs with a high incidence in many countries in south-eastern Asia. Chromosomal abnormalities have been commonly found in NPC, but the underlying mechanism is not well understood. We determined mitotic indices, the staining pattern of nuclear DNA and cell cycle profiles of NPC cells in response to treatment with microtubule-disrupting agents, and found that the mitotic checkpoint was defective in two out of five (40%) of the tested NPC cell lines. We also observed that an aberrantly reduced expression of MAD2, one of the key components of mitotic checkpoint, correlated with the loss of checkpoint control. Our findings suggest that a defective mitotic checkpoint characterized by reduced expression of MAD2 contributes to chromosomal instability in NPC.

10 August 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
XSXiaopeng Shen
Xiaopeng Shen
BSBenjamin Soibam
Benjamin Soibam
ABAshley Benham
Ashley Benham
XXXueping Xu
Xueping Xu
MCMani Chopra
Mani Chopra
YLYu Liu
Yu Liu
Significance: Compared with microRNAs (miRNAs) enriched in cardiac and skeletal muscles, little is known about miRNAs expressed in early cardiac progenitors. Here, we show that mesoderm posterior 1 (Mesp1) transactivates a large number of miRNAs that may promote cardiomyocyte formation. The miR-322/-503 cluster has the highest enrichment in the Mesp1 lineage of cardiac progenitor cells, is specifically expressed in the developing heart tube, and drives precocious cardiomyocyte formation by targeting an RNA-binding factor, CUG-binding protein Elav-like family member 1 (Celf1). This study fills a gap in our knowledge about miRNAs acting early in the cardiac program and identifies previously unreported candidates in promoting cardiac regeneration.

1 July 2000 in Life Sciences
Verified
Journal Article
Closed access
LFL.F. Fung
L.F. Fung
ALAngela K.F. Lo
Angela K.F. Lo
PYP.W. Yuen
P.W. Yuen
YLY. Liu
Y. Liu
XWX.H. Wang
X.H. Wang
STS.W. Tsao
S.W. Tsao